Heart attacks and homocysteine.
作者信息
Graham I, Meleady R
出版信息
BMJ. 1996 Dec 7;313(7070):1419-20. doi: 10.1136/bmj.313.7070.1419.
Abstract
摘要
相似文献
1
Heart attacks and homocysteine.心脏病发作与同型半胱氨酸
BMJ. 1996 Dec 7;313(7070):1419-20. doi: 10.1136/bmj.313.7070.1419.
2
The enigma of ENIGMA-I.
Anesth Analg. 2011 Feb;112(2):255-7. doi: 10.1213/ANE.0b013e3182032521.
3
[Increased homocysteine level--a risk factor for myocardial infarct?].[同型半胱氨酸水平升高——心肌梗死的一个风险因素？]
Med Monatsschr Pharm. 1993 Nov;16(11):336-7.
4
Homocysteine is an independent risk factor for myocardial infarction, in particular fatal myocardial infarction in middle-aged women.
Circulation. 2004 Jul 27;110(4):e37-8; author reply e37-8. doi: 10.1161/01.CIR.0000136200.18448.37.
5
[Significance of homocysteines in the development of acute myocardial infarction].[同型半胱氨酸在急性心肌梗死发生中的意义]
Georgian Med News. 2005 Apr(121):64-7.
6
The plasma homocysteine concentrations and prior myocardial infarction.
Rom J Intern Med. 2010;48(1):65-72.
7
Plasma homocysteine level and myocardial infarction: how high is high enough to need intervention?
South Med J. 2006 Aug;99(8):796-7. doi: 10.1097/01.smj.0000231248.62486.16.
8
The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study.同型半胱氨酸与心肌梗死之间的关联独立于年龄、性别、血压、胆固醇、吸烟及炎症标志物：格拉斯哥心肌梗死研究。
Blood Coagul Fibrinolysis. 2006 Jan;17(1):1-5. doi: 10.1097/01.mbc.0000195919.71950.f7.
9
Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.降低同型半胱氨酸预防心血管事件的试验：大型随机试验的设计与效能综述
Am Heart J. 2006 Feb;151(2):282-7. doi: 10.1016/j.ahj.2005.04.025.
10
[PS on homocysteine as a risk factor of cardiovascular disease].[关于同型半胱氨酸作为心血管疾病风险因素的附言]
Lakartidningen. 2000 May 31;97(22):2786-7.
引用本文的文献
1
Evaluation of Oxidative Stress and hsCRP in Polycystic Ovarian Syndrome in a Tertiary Care Hospital.三级护理医院中多囊卵巢综合征患者氧化应激和超敏C反应蛋白的评估
Indian J Clin Biochem. 2015 Apr;30(2):161-6. doi: 10.1007/s12291-014-0427-3. Epub 2014 Apr 6.
2
Cobalamin status in children.儿童钴胺素状况。
J Inherit Metab Dis. 2011 Feb;34(1):111-9. doi: 10.1007/s10545-010-9119-1. Epub 2010 May 27.
3
Does folate therapy reduce the risk of coronary restenosis?叶酸治疗是否能降低冠状动脉再狭窄的风险？
Neth Heart J. 2007 Jan;15(1):12-5. doi: 10.1007/BF03086052.
4
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS).多囊卵巢综合征（PCOS）女性的心血管风险。
J Clin Pathol. 2005 Feb;58(2):151-4. doi: 10.1136/jcp.2003.015271.
5
Similarities in the epidemiology of neural tube defects and coronary heart disease: is homocysteine the missing link?神经管缺陷与冠心病流行病学的相似之处：同型半胱氨酸是其中缺失的环节吗？
J Epidemiol Community Health. 1999 Dec;53(12):789-93. doi: 10.1136/jech.53.12.789.
6
An audit of the investigation and treatment of folic acid deficiency.一项关于叶酸缺乏症调查与治疗的审计。
J R Soc Med. 1998 Feb;91(2):72-3. doi: 10.1177/014107689809100205.
本文引用的文献
1
Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction.
QJM. 1996 Jun;89(6):437-44. doi: 10.1093/qjmed/89.6.437.
2
Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation.亚甲基四氢叶酸还原酶（MTHFR）C677T突变在健康人群和冠心病患者中的分布情况。
Arterioscler Thromb Vasc Biol. 1996 Jul;16(7):878-82. doi: 10.1161/01.atv.16.7.878.
3
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.叶酸状态、亚甲基四氢叶酸还原酶常见突变与血浆同型半胱氨酸浓度之间的关系。
Circulation. 1996 Jan 1;93(1):7-9. doi: 10.1161/01.cir.93.1.7.
4
Serum total homocysteine and coronary heart disease.血清总同型半胱氨酸与冠心病
Int J Epidemiol. 1995 Aug;24(4):704-9. doi: 10.1093/ije/24.4.704.
5
Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?
Q J Med. 1993 Oct;86(10):685-9. doi: 10.1093/qjmed/86.10.685.
6
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.血浆同型半胱氨酸作为早发家族性冠状动脉疾病的一个危险因素。
Clin Chem. 1994 Apr;40(4):552-61.
7
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.维生素状态和摄入量作为老年人群高同型半胱氨酸血症的主要决定因素。
JAMA. 1993 Dec 8;270(22):2693-8. doi: 10.1001/jama.1993.03510220049033.
8
Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people.有代谢方面的证据表明，维生素B-12（钴胺素）、叶酸和维生素B-6缺乏在老年人中普遍存在。
Am J Clin Nutr. 1993 Oct;58(4):468-76. doi: 10.1093/ajcn/58.4.468.
9
Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.热不稳定型5,10-亚甲基四氢叶酸还原酶作为轻度高同型半胱氨酸血症的一个病因
Am J Hum Genet. 1995 Jan;56(1):142-50.
10
Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.高同型半胱氨酸血症与低磷酸吡哆醛。冠状动脉疾病常见且独立的可逆危险因素。
Circulation. 1995 Nov 15;92(10):2825-30. doi: 10.1161/01.cir.92.10.2825.
Zotero 插件